Drug Type Monoclonal antibody |
Synonyms KHK 2823, KHK2823 |
Target |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 1 | GB | 01 Jun 2014 | |
Myelodysplastic Syndromes | Phase 1 | GB | 01 Jun 2014 | |
Myelodysplastic Syndromes | Phase 1 | GB | 01 Jun 2014 | |
Refractory acute myeloid leukemia | Phase 1 | GB | 01 Jun 2014 |